Company News

2015.09.23

High-end Dialogue at 2015 Shenzhen International BT leaders summit
High-end Dialogue at 2015 Shenzhen International BT leaders summit

Full text

2015.05.25

[ Leading scientific and technological innovation in China ] Lu Xianping: to be a life-saving medicine that people can afford.
[ Leading scientific and technological innovation in China ] Lu Xianping: to be a life-saving medicine that people can afford.

Full text

2015.04.17

Shenzhen CHIPSCREEN BIOSCIENCES approved the establishment of " Shenzhen postdoctoral innovation practice base"
Shenzhen CHIPSCREEN BIOSCIENCES approved the establishment of " Shenzhen postdoctoral innovation practice base"

Full text

2015.02.17

Dr. Lu Xianping was invited to attend the " frontier seminar on tumor biology and new drug development" of the HongKong polytechnic University and give a report.
Dr. Lu Xianping was invited to attend the " frontier seminar on tumor biology and new drug development" of the HongKong polytechnic University and give a report.

Full text

2015.01.28

Chidamide press conference on original new drugs, national 863 and " major new drug discovery" special achievements held in Shenzhen
Chidamide press conference on original new drugs, national 863 and " major new drug discovery" special achievements held in Shenzhen

Full text

2015.01.09

The world's first subtype of selective histone deacetylase oral inhibitor original new drug Chidamide ( Epidaza? ) approved!
The world's first subtype of selective histone deacetylase oral inhibitor original new drug Chidamide ( Epidaza? ) approved!

Full text

2014.12.21

CHIPSCREEN BIOSCIENCES, Shenzhen inspected by national major new drug discovery, science and technology major special supervision and evaluation team.
CHIPSCREEN BIOSCIENCES, Shenzhen inspected by national major new drug discovery, science and technology major special supervision and evaluation team.

Full text

2014.11.16

Shenzhen CHIPSCREEN BIOSCIENCES won " BayHelix Award for R&D Achievement of the Year 2014"
Shenzhen CHIPSCREEN BIOSCIENCES won " BayHelix Award for R&D Achievement of the Year 2014"

Full text

2014.11.10

Chengdu CHIPSCREEN pharmaceutical co., ltd. undertakes " China pharmaceutical innovation forum - 2014 Chengdu jinqiu lunjian"
Chengdu CHIPSCREEN pharmaceutical co., ltd. undertakes " China pharmaceutical innovation forum - 2014 Chengdu jinqiu lunjian"

Full text

2014.10.24

Dr. Lu Xianping was invited to attend the fourth international conference on epigenetics of tumors and give a report.
Dr. Lu Xianping was invited to attend the fourth international conference on epigenetics of tumors and give a report.

Full text

2014.10.24

Dr. Lu Xianping was invited to attend and give a report on Wuxi Yao Ming Kant's WX Science Seminar Committee
Dr. Lu Xianping was invited to attend and give a report on Wuxi Yao Ming Kant's WX Science Seminar Committee

Full text

2014.10.18

Dr. Lu Xianping was invited to attend the 2014 international symposium on chemistry and life sciences and make a report.
Dr. Lu Xianping was invited to attend the 2014 international symposium on chemistry and life sciences and make a report.

Full text

2014.10.14

Dr. Lu Xianping was invited to take part in the 10th anniversary of the forum with freehand brushwork - " looking for the soul of Chinese new medicine" and make a report.
Dr. Lu Xianping was invited to take part in the 10th anniversary of the forum with freehand brushwork - " looking for the soul of Chinese new medicine" and make a report.

Full text

2014.09.01

National " major new drug discovery" inspection of Shenzhen CHIPSCREEN BIOSCIENCES
National " major new drug discovery" inspection of Shenzhen CHIPSCREEN BIOSCIENCES

Full text

2014.08.05

Dr. Lu Xianping was invited to serve as a mentor for the first phase of the "one thousand people plan" to earn foreign exchange through the sea
Dr. Lu Xianping was invited to serve as a mentor for the first phase of the "one thousand people plan" to earn foreign exchange through the sea

Full text

News & Events

Chipscreen Highlights: Stay Updated on Recent Hot Topics

Select year

High-end Dialogue at 2015 Shenzhen International BT leaders summit
High-end Dialogue at 2015 Shenzhen International BT leaders summit

[ Leading scientific and technological innovation in China ] Lu Xianping: to be a life-saving medicine that people can afford.
[ Leading scientific and technological innovation in China ] Lu Xianping: to be a life-saving medicine that people can afford.

Shenzhen CHIPSCREEN BIOSCIENCES approved the establishment of " Shenzhen postdoctoral innovation practice base"
Shenzhen CHIPSCREEN BIOSCIENCES approved the establishment of " Shenzhen postdoctoral innovation practice base"

Chidamide press conference on original new drugs, national 863 and " major new drug discovery" special achievements held in Shenzhen
Chidamide press conference on original new drugs, national 863 and " major new drug discovery" special achievements held in Shenzhen

The world's first subtype of selective histone deacetylase oral inhibitor original new drug Chidamide ( Epidaza? ) approved!
The world's first subtype of selective histone deacetylase oral inhibitor original new drug Chidamide ( Epidaza? ) approved!

Shenzhen CHIPSCREEN BIOSCIENCES won " BayHelix Award for R&D Achievement of the Year 2014"
Shenzhen CHIPSCREEN BIOSCIENCES won " BayHelix Award for R&D Achievement of the Year 2014"

Chengdu CHIPSCREEN pharmaceutical co., ltd. undertakes " China pharmaceutical innovation forum - 2014 Chengdu jinqiu lunjian"
Chengdu CHIPSCREEN pharmaceutical co., ltd. undertakes " China pharmaceutical innovation forum - 2014 Chengdu jinqiu lunjian"

Dr. Lu Xianping was invited to attend the fourth international conference on epigenetics of tumors and give a report.
Dr. Lu Xianping was invited to attend the fourth international conference on epigenetics of tumors and give a report.

Dr. Lu Xianping was invited to attend and give a report on Wuxi Yao Ming Kant's WX Science Seminar Committee
Dr. Lu Xianping was invited to attend and give a report on Wuxi Yao Ming Kant's WX Science Seminar Committee

Dr. Lu Xianping was invited to attend the 2014 international symposium on chemistry and life sciences and make a report.
Dr. Lu Xianping was invited to attend the 2014 international symposium on chemistry and life sciences and make a report.

National " major new drug discovery" inspection of Shenzhen CHIPSCREEN BIOSCIENCES
National " major new drug discovery" inspection of Shenzhen CHIPSCREEN BIOSCIENCES

Dr. Lu Xianping was invited to serve as a mentor for the first phase of the "one thousand people plan" to earn foreign exchange through the sea
Dr. Lu Xianping was invited to serve as a mentor for the first phase of the "one thousand people plan" to earn foreign exchange through the sea

Media contact

News & Events

Chipscreen Highlights: Stay Updated on Recent Hot Topics

Select year

High-end Dialogue at 2015 Shenzhen International BT leaders summitHigh-end Dialogue at 2015 Shenzhen International BT leaders summit

[ Leading scientific and technological innovation in China ] Lu Xianping: to be a life-saving medicine that people can afford.[ Leading scientific and technological innovation in China ] Lu Xianping: to be a life-saving medicine that people can afford.

Shenzhen CHIPSCREEN BIOSCIENCES approved the establishment of " Shenzhen postdoctoral innovation practice base"Shenzhen CHIPSCREEN BIOSCIENCES approved the establishment of " Shenzhen postdoctoral innovation practice base"

Chidamide press conference on original new drugs, national 863 and " major new drug discovery" special achievements held in ShenzhenChidamide press conference on original new drugs, national 863 and " major new drug discovery" special achievements held in Shenzhen

The world's first subtype of selective histone deacetylase oral inhibitor original new drug Chidamide ( Epidaza? ) approved!The world's first subtype of selective histone deacetylase oral inhibitor original new drug Chidamide ( Epidaza? ) approved!

Shenzhen CHIPSCREEN BIOSCIENCES won " BayHelix Award for R&D Achievement of the Year 2014"Shenzhen CHIPSCREEN BIOSCIENCES won " BayHelix Award for R&D Achievement of the Year 2014"

Chengdu CHIPSCREEN pharmaceutical co., ltd. undertakes " China pharmaceutical innovation forum - 2014 Chengdu jinqiu lunjian"Chengdu CHIPSCREEN pharmaceutical co., ltd. undertakes " China pharmaceutical innovation forum - 2014 Chengdu jinqiu lunjian"

Dr. Lu Xianping was invited to attend the fourth international conference on epigenetics of tumors and give a report.Dr. Lu Xianping was invited to attend the fourth international conference on epigenetics of tumors and give a report.

Dr. Lu Xianping was invited to attend and give a report on Wuxi Yao Ming Kant's WX Science Seminar CommitteeDr. Lu Xianping was invited to attend and give a report on Wuxi Yao Ming Kant's WX Science Seminar Committee

Dr. Lu Xianping was invited to attend the 2014 international symposium on chemistry and life sciences and make a report.Dr. Lu Xianping was invited to attend the 2014 international symposium on chemistry and life sciences and make a report.

National " major new drug discovery" inspection of Shenzhen CHIPSCREEN BIOSCIENCESNational " major new drug discovery" inspection of Shenzhen CHIPSCREEN BIOSCIENCES

Dr. Lu Xianping was invited to serve as a mentor for the first phase of the "one thousand people plan" to earn foreign exchange through the seaDr. Lu Xianping was invited to serve as a mentor for the first phase of the "one thousand people plan" to earn foreign exchange through the sea

Media contact

High-end Dialogue at 2015 Shenzhen International BT leaders summit
High-end Dialogue at 2015 Shenzhen International BT leaders summit

[ Leading scientific and technological innovation in China ] Lu Xianping: to be a life-saving medicine that people can afford.
[ Leading scientific and technological innovation in China ] Lu Xianping: to be a life-saving medicine that people can afford.

Shenzhen CHIPSCREEN BIOSCIENCES approved the establishment of " Shenzhen postdoctoral innovation practice base"
Shenzhen CHIPSCREEN BIOSCIENCES approved the establishment of " Shenzhen postdoctoral innovation practice base"

Chidamide press conference on original new drugs, national 863 and " major new drug discovery" special achievements held in Shenzhen
Chidamide press conference on original new drugs, national 863 and " major new drug discovery" special achievements held in Shenzhen

The world's first subtype of selective histone deacetylase oral inhibitor original new drug Chidamide ( Epidaza? ) approved!
The world's first subtype of selective histone deacetylase oral inhibitor original new drug Chidamide ( Epidaza? ) approved!

Shenzhen CHIPSCREEN BIOSCIENCES won " BayHelix Award for R&D Achievement of the Year 2014"
Shenzhen CHIPSCREEN BIOSCIENCES won " BayHelix Award for R&D Achievement of the Year 2014"

Chengdu CHIPSCREEN pharmaceutical co., ltd. undertakes " China pharmaceutical innovation forum - 2014 Chengdu jinqiu lunjian"
Chengdu CHIPSCREEN pharmaceutical co., ltd. undertakes " China pharmaceutical innovation forum - 2014 Chengdu jinqiu lunjian"

Dr. Lu Xianping was invited to attend the fourth international conference on epigenetics of tumors and give a report.
Dr. Lu Xianping was invited to attend the fourth international conference on epigenetics of tumors and give a report.

Dr. Lu Xianping was invited to attend and give a report on Wuxi Yao Ming Kant's WX Science Seminar Committee
Dr. Lu Xianping was invited to attend and give a report on Wuxi Yao Ming Kant's WX Science Seminar Committee

Dr. Lu Xianping was invited to attend the 2014 international symposium on chemistry and life sciences and make a report.
Dr. Lu Xianping was invited to attend the 2014 international symposium on chemistry and life sciences and make a report.

National " major new drug discovery" inspection of Shenzhen CHIPSCREEN BIOSCIENCES
National " major new drug discovery" inspection of Shenzhen CHIPSCREEN BIOSCIENCES

Dr. Lu Xianping was invited to serve as a mentor for the first phase of the "one thousand people plan" to earn foreign exchange through the sea
Dr. Lu Xianping was invited to serve as a mentor for the first phase of the "one thousand people plan" to earn foreign exchange through the sea